Orphan drugs: Regulation is flawed

Research output: Contribution to journalLetter

Original languageEnglish
Article numberc7016
JournalBMJ (Clinical research ed.)
Volume341
DOIs
Publication statusPublished - 7 Dec 2010

Keywords

  • 4-aminopyridine
  • drug approval
  • humans
  • orphan drug production
  • potassium channel blockers
  • quality control
  • randomized controlled trials as topic

Cite this

Orphan drugs : Regulation is flawed. / Counsell, Carl E.

In: BMJ (Clinical research ed.), Vol. 341, c7016, 07.12.2010.

Research output: Contribution to journalLetter

@article{38b322e6e6a04787a637bf82bbae4571,
title = "Orphan drugs: Regulation is flawed",
keywords = "4-aminopyridine, drug approval, humans, orphan drug production, potassium channel blockers, quality control, randomized controlled trials as topic",
author = "Counsell, {Carl E}",
year = "2010",
month = "12",
day = "7",
doi = "10.1136/bmj.c7016",
language = "English",
volume = "341",
journal = "BMJ",
issn = "0959-8146",
publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Orphan drugs

T2 - Regulation is flawed

AU - Counsell, Carl E

PY - 2010/12/7

Y1 - 2010/12/7

KW - 4-aminopyridine

KW - drug approval

KW - humans

KW - orphan drug production

KW - potassium channel blockers

KW - quality control

KW - randomized controlled trials as topic

U2 - 10.1136/bmj.c7016

DO - 10.1136/bmj.c7016

M3 - Letter

C2 - 21139004

VL - 341

JO - BMJ

JF - BMJ

SN - 0959-8146

M1 - c7016

ER -